Simultaneous carotid endarterectomy and myocardial revascularization by using cardiopulmonary bypass for both

Tekin Yildirim1, Cengiz Koksal, Hakan Kiniklioglu

  • 1Department of Cardiovascular Surgery, Goztepe Safak Hospital, Istanbul, Turkey. ty@ttnet.net.tr

Acta Cardiologica
|January 3, 2006
PubMed

Insights

Simultaneous carotid endarterectomy and coronary bypass surgery performed under cardiopulmonary bypass is a safe procedure. This combined approach offers acceptable morbidity and mortality rates for patients with both coronary and carotid arterial disease.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Surgery
  • Cerebrovascular Surgery

Background:

  • Optimal treatment for patients with co-existing coronary and carotid arterial disease remains controversial.
  • Simultaneous surgical intervention is an option, but its safety and efficacy require further investigation.

Purpose of the Study:

  • To evaluate the safety and outcomes of performing simultaneous carotid endarterectomy and coronary artery bypass grafting.
  • To assess the combined procedure's morbidity and mortality rates.

Main Methods:

  • Seventy-two patients with both coronary and carotid arterial disease underwent simultaneous carotid endarterectomy and coronary artery bypass grafting.
  • The combined procedure was performed during cardiopulmonary bypass with mild hypothermia and pulsatile perfusion for cerebral protection.
  • Indications for carotid endarterectomy included >75% lumen diameter reduction or unstable plaque.

Main Results:

  • The mean cardiopulmonary bypass time was 64.7 minutes and aortic cross-clamp time was 32.4 minutes.
  • Perioperative neurological complications occurred in 5.5% of patients, with permanent deficits in 2.7%.
  • The procedure-related mortality rate was 4.1%.

Conclusions:

  • Simultaneous carotid endarterectomy and coronary artery bypass grafting under cardiopulmonary bypass is a safe and feasible surgical option.
  • The combined procedure demonstrates acceptable morbidity and mortality rates for selected patients.
  • This approach offers a viable solution for managing complex cardiovascular and cerebrovascular disease concurrently.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...